全文获取类型
收费全文 | 10092篇 |
免费 | 959篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 280篇 |
妇产科学 | 183篇 |
基础医学 | 1343篇 |
口腔科学 | 263篇 |
临床医学 | 1133篇 |
内科学 | 1740篇 |
皮肤病学 | 207篇 |
神经病学 | 1061篇 |
特种医学 | 604篇 |
外科学 | 1429篇 |
综合类 | 304篇 |
一般理论 | 6篇 |
预防医学 | 1023篇 |
眼科学 | 239篇 |
药学 | 843篇 |
中国医学 | 13篇 |
肿瘤学 | 397篇 |
出版年
2022年 | 59篇 |
2021年 | 157篇 |
2020年 | 100篇 |
2019年 | 171篇 |
2018年 | 194篇 |
2017年 | 156篇 |
2016年 | 133篇 |
2015年 | 178篇 |
2014年 | 224篇 |
2013年 | 343篇 |
2012年 | 551篇 |
2011年 | 543篇 |
2010年 | 266篇 |
2009年 | 286篇 |
2008年 | 489篇 |
2007年 | 534篇 |
2006年 | 572篇 |
2005年 | 515篇 |
2004年 | 470篇 |
2003年 | 421篇 |
2002年 | 402篇 |
2001年 | 271篇 |
2000年 | 225篇 |
1999年 | 245篇 |
1998年 | 175篇 |
1997年 | 167篇 |
1996年 | 143篇 |
1995年 | 125篇 |
1994年 | 109篇 |
1993年 | 119篇 |
1992年 | 184篇 |
1991年 | 186篇 |
1990年 | 150篇 |
1989年 | 191篇 |
1988年 | 163篇 |
1987年 | 177篇 |
1986年 | 146篇 |
1985年 | 158篇 |
1984年 | 111篇 |
1983年 | 110篇 |
1982年 | 74篇 |
1981年 | 69篇 |
1980年 | 82篇 |
1979年 | 99篇 |
1978年 | 71篇 |
1977年 | 80篇 |
1976年 | 55篇 |
1975年 | 62篇 |
1974年 | 68篇 |
1973年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
Christopher P. Derry A. Simon Harvey Matthew C. Walker John S. Duncan Samuel F. Berkovic 《Sleep》2009,32(12):1637-1644
Study Objectives.
To describe the semiological features of NREM arousal parasomnias in detail and identify features that can be used to reliably distinguish parasomnias from nocturnal frontal lobe epilepsy (NFLE).Design.
Systematic semiologial evaluation of parasomnias and NFLE seizures recorded on video-EEG monitoring.Patients.
120 events (57 parasomnias, 63 NFLE seizures) from 44 subjects (14 males).Interventions.
The presence or absence of 68 elemental clinical features was determined in parasomnias and NFLE seizures. Qualitative analysis of behavior patterns and ictal EEG was undertaken. Statistical analysis was undertaken using established techniques.Results.
Elemental clinical features strongly favoring parasomnias included: interactive behavior, failure to wake after event, and indistinct offset (all P < 0.001). Cluster analysis confirmed differences in both the frequency and combination of elemental features in parasomnias and NFLE. A diagnostic decision tree generated from these data correctly classified 94% of events. While sleep stage at onset was discriminatory (82% of seizures occurred during stage 1 or 2 sleep, with 100% of parasomnias occurring from stage 3 or 4 sleep), ictal EEG features were less useful. Video analysis of parasomnias identified three principal behavioral patterns: arousal behavior (92% of events); non-agitated motor behavior (72%); distressed emotional behavior (51%).Conclusions
Our results broadly support the concept of confusion arousals, somnambulism and night terrors as prototypical behavior patterns of NREM parasomnias, but as a hierarchical continuum rather than distinct entities. Our observations provide an evidence base to assist in the clinical diagnosis of NREM parasomnias, and their distinction from NFLE seizures, on semiological grounds.Citation:
Derry CP; Harvey AS; Walker MC; Duncan JS; Berkovic SF. NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG analysis. SLEEP 2009;32(12):1637-1644. 相似文献962.
963.
964.
Roopun AK Traub RD Baldeweg T Cunningham MO Whittaker RG Trevelyan A Duncan R Russell AJ Whittington MA 《Epilepsy & behavior : E&B》2009,14(Z1):39-46
Many types of electrographic seizures are readily identifiable by direct visual examination of electroencephalographic or electrocorticographic recordings. This process can, however, be painstakingly slow, and much effort has been expended to automate the process using various dynamic properties of epileptiform waveforms. As methods have become more subtle and powerful they have been used for seizure subclassification, seizure prediction, and seizure onset identification and localization. Here we concentrate on the last, with reference to seizures of neocortical origin. We briefly review some of the methods used and introduce preliminary results from a very simple dynamic model based on key electrophysiological properties found in some seizure types: occurrence of very fast oscillations (sometimes called ripples), excess gamma frequency oscillations, electroencephalographic/electrocorticographic flattening, and changes in global synchrony. We show how this multiscale analysis may reveal features unique to seizure onset and speculate on the underlying cellular and network phenomena responsible. 相似文献
965.
Bonelli SB Powell R Yogarajah M Thompson PJ Symms MR Koepp MJ Duncan JS 《Epilepsia》2009,50(2):217-227
Purpose: Anterior temporal lobe resections (ATLR) benefit 70% of patients with refractory mesial temporal lobe epilepsy (TLE), but may be complicated by emotional disturbances. We used functional magnetic resonance imaging (fMRI) to investigate the role of the amygdala in processing emotions in TLE and whether this may be a potential preoperative predictive marker for emotional disturbances following surgery.
Methods: We studied 54 patients with refractory mesial TLE due to hippocampal sclerosis (28 right, 26 left) and 21 healthy controls using a memory encoding fMRI paradigm, which included viewing fearful and neutral faces. Twenty-one TLE patients (10 left, 11 right) subsequently underwent ATLR. Anxiety and depression were assessed preoperatively and 4 months postoperatively using the Hospital Anxiety and Depression Scale.
Results: On viewing fearful faces, healthy controls demonstrated left lateralized, while right TLE patients showed bilateral amygdala activation. Left TLE patients had significantly reduced activation in left and right amygdalae compared to controls and right TLE patients. In right TLE patients, left and right amygdala activation was significantly related to preoperative anxiety and depression levels, and preoperative right amygdala activation correlated significantly with postoperative change of anxiety and depression scores, characterized by greater increases in anxiety and depression in patients with greater preoperative activation. No such correlations were seen for left TLE patients.
Discussion: The fearful face fMRI paradigm is a reliable method for visualizing amygdala activation in controls and patients with mesial TLE. Activation of the right amygdala preoperatively was predictive of emotional disturbances following right ATLR. 相似文献
Methods: We studied 54 patients with refractory mesial TLE due to hippocampal sclerosis (28 right, 26 left) and 21 healthy controls using a memory encoding fMRI paradigm, which included viewing fearful and neutral faces. Twenty-one TLE patients (10 left, 11 right) subsequently underwent ATLR. Anxiety and depression were assessed preoperatively and 4 months postoperatively using the Hospital Anxiety and Depression Scale.
Results: On viewing fearful faces, healthy controls demonstrated left lateralized, while right TLE patients showed bilateral amygdala activation. Left TLE patients had significantly reduced activation in left and right amygdalae compared to controls and right TLE patients. In right TLE patients, left and right amygdala activation was significantly related to preoperative anxiety and depression levels, and preoperative right amygdala activation correlated significantly with postoperative change of anxiety and depression scores, characterized by greater increases in anxiety and depression in patients with greater preoperative activation. No such correlations were seen for left TLE patients.
Discussion: The fearful face fMRI paradigm is a reliable method for visualizing amygdala activation in controls and patients with mesial TLE. Activation of the right amygdala preoperatively was predictive of emotional disturbances following right ATLR. 相似文献
966.
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures 总被引:1,自引:0,他引:1
Jesus Eric Piña-Garza †Douglas R. Nordli Jr ‡Dietz Rating §Haichen Yang §Jimmy Schiemann-Delgado §Benjamin Duncan ; on behalf of the Levetiracetam N Study Group 《Epilepsia》2009,50(5):1141-1149
Purpose: To evaluate the efficacy and tolerability of adjunctive levetiracetam in very young children (aged 1 month to <4 years) with partial-onset seizures inadequately controlled with one or two antiepileptic drugs.
Methods: This multicenter, double-blind, randomized, placebo-controlled study consisted of a 48-h inpatient baseline video-EEG (electroencephalography) and a 5-day inpatient treatment period (1-day up-titration; 48-h evaluation video-EEG in the last 2 days). Children who experienced at least two partial-onset seizures during the 48-h baseline video-EEG were randomized to either levetiracetam [40 mg/kg/day (age 1 to <6 months); 50 mg/kg/day (age ≥6 months to <4 years] or placebo.
Results: Of 175 patients screened, 116 patients were randomized [60 levetiracetam; 56 placebo; intent-to-treat (ITT) population], and 111 completed the study. The responder rate in average daily partial-onset seizures frequency (48-h video-EEG monitoring; primary efficacy variable) was 43.1% for levetiracetam [modified ITT (mITT) = 58] versus 19.6% for placebo (mITT = 51; p=0.013), with odds ratio for response 3.11 [95% confidence interval (CI), 1.22–8.26]. The median percent reduction from baseline in average daily partial-onset seizure frequency was 43.6% for levetiracetam and 7.1% for placebo with a median difference between treatment groups of 39.2% (95% CI, 17.5–62.2; p < 0.001). In general, levetiracetam was well tolerated. Treatment-emergent adverse events were reported by 55.0% levetiracetam- and 44.6% placebo-treated patients (ITT population). The most frequently reported adverse events were somnolence (13.3% levetiracetam, 1.8% placebo) and irritability (11.7% levetiracetam, 0% placebo).
Discussion: Adjunctive levetiracetam is an efficacious and well-tolerated treatment for partial-onset seizures in infants and young children. 相似文献
Methods: This multicenter, double-blind, randomized, placebo-controlled study consisted of a 48-h inpatient baseline video-EEG (electroencephalography) and a 5-day inpatient treatment period (1-day up-titration; 48-h evaluation video-EEG in the last 2 days). Children who experienced at least two partial-onset seizures during the 48-h baseline video-EEG were randomized to either levetiracetam [40 mg/kg/day (age 1 to <6 months); 50 mg/kg/day (age ≥6 months to <4 years] or placebo.
Results: Of 175 patients screened, 116 patients were randomized [60 levetiracetam; 56 placebo; intent-to-treat (ITT) population], and 111 completed the study. The responder rate in average daily partial-onset seizures frequency (48-h video-EEG monitoring; primary efficacy variable) was 43.1% for levetiracetam [modified ITT (mITT) = 58] versus 19.6% for placebo (mITT = 51; p=0.013), with odds ratio for response 3.11 [95% confidence interval (CI), 1.22–8.26]. The median percent reduction from baseline in average daily partial-onset seizure frequency was 43.6% for levetiracetam and 7.1% for placebo with a median difference between treatment groups of 39.2% (95% CI, 17.5–62.2; p < 0.001). In general, levetiracetam was well tolerated. Treatment-emergent adverse events were reported by 55.0% levetiracetam- and 44.6% placebo-treated patients (ITT population). The most frequently reported adverse events were somnolence (13.3% levetiracetam, 1.8% placebo) and irritability (11.7% levetiracetam, 0% placebo).
Discussion: Adjunctive levetiracetam is an efficacious and well-tolerated treatment for partial-onset seizures in infants and young children. 相似文献
967.
968.
André O von Bueren Christoph Oehler Tarek Shalaby Katja von Hoff Martin Pruschy Burkhardt Seifert Nicolas U Gerber Monika Warmuth-Metz Duncan Stearns Charles G Eberhart Rolf D Kortmann Stefan Rutkowski Michael A Grotzer 《BMC cancer》2011,11(1):1-11
Background
KLK15 over-expression is reported to be a significant predictor of reduced progression-free survival and overall survival in ovarian cancer. Our aim was to analyse the KLK15 gene for putative functional single nucleotide polymorphisms (SNPs) and assess the association of these and KLK15 HapMap tag SNPs with ovarian cancer survival.Results
In silico analysis was performed to identify KLK15 regulatory elements and to classify potentially functional SNPs in these regions. After SNP validation and identification by DNA sequencing of ovarian cancer cell lines and aggressive ovarian cancer patients, 9 SNPs were shortlisted and genotyped using the Sequenom iPLEX Mass Array platform in a cohort of Australian ovarian cancer patients (N = 319). In the Australian dataset we observed significantly worse survival for the KLK15 rs266851 SNP in a dominant model (Hazard Ratio (HR) 1.42, 95% CI 1.02-1.96). This association was observed in the same direction in two independent datasets, with a combined HR for the three studies of 1.16 (1.00-1.34). This SNP lies 15bp downstream of a novel exon and is predicted to be involved in mRNA splicing. The mutant allele is also predicted to abrogate an HSF-2 binding site.Conclusions
We provide evidence of association for the SNP rs266851 with ovarian cancer survival. Our results provide the impetus for downstream functional assays and additional independent validation studies to assess the role of KLK15 regulatory SNPs and KLK15 isoforms with alternative intracellular functional roles in ovarian cancer survival. 相似文献969.
970.
Frank Reimann James J. Cox Inna Belfer Luda Diatchenko Dmitri V. Zaykin Duncan P. McHale Joost P. H. Drenth Feng Dai Jerry Wheeler Frances Sanders Linda Wood Tian-Xia Wu Jaro Karppinen Lone Nikolajsen Minna M?nnikk? Mitchell B. Max Carly Kiselycznyk Minakshi Poddar Rene H.M. te Morsche Shad Smith Dustin Gibson Anthi Kelempisioti William Maixner Fiona M. Gribble C. Geoffrey Woods 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(11):5148-5153
The gene SCN9A is responsible for three human pain disorders. Nonsense mutations cause a complete absence of pain, whereas activating mutations cause severe episodic pain in paroxysmal extreme pain disorder and primary erythermalgia. This led us to investigate whether single nucleotide polymorphisms (SNPs) in SCN9A were associated with differing pain perception in the general population. We first genotyped 27 SCN9A SNPs in 578 individuals with a radiographic diagnosis of osteoarthritis and a pain score assessment. A significant association was found between pain score and SNP rs6746030; the rarer A allele was associated with increased pain scores compared to the commoner G allele (P = 0.016). This SNP was then further genotyped in 195 pain-assessed people with sciatica, 100 amputees with phantom pain, 179 individuals after lumbar discectomy, and 205 individuals with pancreatitis. The combined P value for increased A allele pain was 0.0001 in the five cohorts tested (1277 people in total). The two alleles of the SNP rs6746030 alter the coding sequence of the sodium channel Nav1.7. Each was separately transfected into HEK293 cells and electrophysiologically assessed by patch-clamping. The two alleles showed a difference in the voltage-dependent slow inactivation (P = 0.042) where the A allele would be predicted to increase Nav1.7 activity. Finally, we genotyped 186 healthy females characterized by their responses to a diverse set of noxious stimuli. The A allele of rs6746030 was associated with an altered pain threshold and the effect mediated through C-fiber activation. We conclude that individuals experience differing amounts of pain, per nociceptive stimulus, on the basis of their SCN9A rs6746030 genotype. 相似文献